Surveillance Registry Of Sirolimus Use In Recipients Of Kidney Allograft From Expanded Criteria Donors (ECD)
Phase of Trial: Phase IV
Latest Information Update: 01 Oct 2016
At a glance
- Drugs Sirolimus (Primary)
- Indications Renal transplant rejection
- Focus Therapeutic Use
- Sponsors Pfizer; Wyeth
- 01 Oct 2016 Results published in the Transplantation Proceedings.
- 02 Jan 2013 Planned End Date changed from 1 Dec 2012 to 1 Feb 2013 as reported by ClinicalTrials.gov record.
- 01 Dec 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.